Effects of CYP1A2 and ADORA2A Genotypes on the Ergogenic Response to Caffeine in Professional Handball Players
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Previous investigations have found that several genes may be associated with the interindividual variability to the ergogenic response to caffeine. The aim of this study is to analyze the influence of the genetic variations in CYP1A2 (−163C > A, rs762551; characterized such as “fast” (AA genotype) and “slow” caffeine metabolizers (C-carriers)) and ADORA2A (1976T > C; rs5751876; characterized by “high” (TT genotype) or “low” sensitivity to caffeine (C-carriers)) on the ergogenic response to acute caffeine intake in professional handball players. Thirty-one professional handball players (sixteen men and fifteen women; daily caffeine intake = 60 ± 25 mg·d−1) ingested 3 mg·kg−1·body mass (bm) of caffeine or placebo 60 min before undergoing a battery of performance tests consisting of a countermovement jump (CMJ), a sprint test, an agility test, an isometric handgrip test, and several ball throws. Afterwards, the handball players performed a simulated handball match (2 × 20 min) while movements were recorded using inertial units. Saliva samples were analyzed to determine the genotype of each player for the −163C > A polymorphism in the CYP1A2 gene (rs762551) and for the 1976T > C polymorphism in the ADORA2A gene (rs5751876). In the CYP1A2, C-allele carriers (54.8%) were compared to AA homozygotes (45.2%). In the ADORA2A, C-allele carriers (80.6%) were compared to TT homozygotes (19.4%). There was only a genotype x treatment interaction for the ball throwing from 7 m (p = 0.037) indicating that the ergogenic effect of caffeine on this test was higher in CYP1A2 AA homozygotes than in C-allele carriers. In the remaining variables, there were no genotype x treatment interactions for CYP1A2 or for ADORA2A. As a whole group, caffeine increased CMJ height, performance in the sprint velocity test, and ball throwing velocity from 9 m (2.8–4.3%, p = 0.001–0.022, effect size = 0.17–0.31). Thus, pre-exercise caffeine supplementation at a dose of 3 mg·kg−1·bm can be considered as an ergogenic strategy to enhance some neuromuscular aspects of handball performance in professional handball players with low daily caffeine consumption. However, the ergogenic response to acute caffeine intake was not modulated by CYP1A2 or ADORA2A genotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IOC Consensus Statement: Dietary Supplements and the High-performance Athlete
Maughan, R. J., Burke, L. M., Dvorak, J., Larson-Meyer, D. E., Peeling, P., Phillips, S. M., Rawson, E. S., Walsh, N. P., Garthe, I., Geyer, H., et al. (2018) · British Journal of Sports Medicine · doi:10.1136/bjsports-2018-099027 · Cited by 1,004
Sachse, C., Brockmöller, J., Bauer, S., & Roots, I. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00898.x · Cited by 751
Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption
Nehlig, A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014407 · Cited by 632 · cited 4×
“These findings do not dispute the notion that the AA genotype increases the metabolism of caffeine, as previously found [28].”
BackgroundResultInfluentialMetabolic, Catecholamine, and Exercise Performance Responses to Various Doses of Caffeine
Graham, T. E., & Spriet, L. L. (1995) · Journal of Applied Physiology · doi:10.1152/jappl.1995.78.3.867 · Cited by 488 · cited 1×
“Interindividual variations in the ergogenic response to caffeine may be attributed to different factors such as training status [14], sex [15], caffeine ingestion method [16], caffeine dosage [17,18], habitual caffeine intake [19], time-of-day when caffeine is consumed [20,21] and genotype variation [22–24].”
BackgroundKamimori, G. H., Karyekar, C. S., Otterstetter, R., Cox, D. S., Balkin, T. J., Belenky, G. L., & Eddington, N. D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00958-9 · Cited by 449 · cited 1×
“Interindividual variations in the ergogenic response to caffeine may be attributed to different factors such as training status [14], sex [15], caffeine ingestion method [16], caffeine dosage [17,18], habitual caffeine intake [19], time-of-day when caffeine is consumed [20,21] and genotype variation [22–24].”
BackgroundDel Coso, J., Muñoz, G., & Muñoz-Guerra, J. (2011) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h11-052 · Cited by 258 · cited 2×
“Although caffeine was considered a banned substance in sports and its use was prohibited in competition between 1984 and 2004 (an adverse analytical finding was reported when urinary caffeine concentration surpassed 12 μg/mL [1]), the wide accessibility and popularity of caffeine-containing sources, and the relatively…”
BackgroundSouthward, K., Rutherfurd-Markwick, K. J., & Ali, A. (2018) · Sports Medicine · doi:10.1007/s40279-018-0939-8 · Cited by 254 · cited 1×
“Different studies have found that ingestion of low-to-moderate doses of caffeine (3–6 mg·kg−1·bm) may have the potential to enhance performance in individual [5] and team sports [6].”
BackgroundCaffeine, CYP1A2 Genotype, and Endurance Performance in Athletes
GUEST, N., COREY, P., VESCOVI, J., & EL-SOHEMY, A. (2018) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001596 · Cited by 231 · cited 3×
“Thus, despite findings associated with a higher ergogenic response to caffeine in CYP1A2 AA athletes with respect to C-allele athletes [22,29], the current investigation suggests that the ergogenic effect of caffeine on neuromuscular performance may be independent of the −163 C > A CYP1A2 genotype, at least in handbal…”
BackgroundMethodResultEffects of a Caffeine-Containing Energy Drink on Simulated Soccer Performance
Del Coso, J., Muñoz-Fernández, V. E., Muñoz, G., Fernández-Elías, V. E., Ortega, J. F., Hamouti, N., Barbero, J. C., & Muñoz-Guerra, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031380 · Cited by 148
Time course of tolerance to the performance benefits of caffeine
Lara, B., Ruiz-Moreno, C., Salinero, J. J., & Del Coso, J. (2019) · PLOS ONE · doi:10.1371/journal.pone.0210275 · Cited by 142 · cited 1×
“Of note, as there is a progressive tolerance to the ergogenic benefit of caffeine with chronic ingestion [60], together with a progressive increase in the prevalence of side effects [61] professional handball players should avoid using caffeine on a daily basis to prevent habituation.”
Background
Cited by
Caffeine, CYP1A2 Genotype, and Exercise Performance: A Systematic Review and Meta-Analysis
BARRETO, G., ESTEVES, G. P., MARTICORENA, F., OLIVEIRA, T. N., GRGIC, J., & SAUNDERS, B. (2024) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003313 · Cited by 27
Silva, H., Del Coso, J., & Pickering, C. (2025) · Sports Medicine · doi:10.1007/s40279-025-02245-y · Cited by 21
“However, in the context of exercise, various studies have reported similar ergogenic effects of caffeine, despite interindividual differences in these genotypes [111, 120].”
Metadata
- Authors
- Muñoz, A., López-Samanes, Á., Aguilar-Navarro, M., Varillas-Delgado, D., Rivilla-García, J., Moreno-Pérez, V., & Del Coso, J.
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2020-08-13
- Volume
- 11
- Issue
- 8
- Pages
- 933
- ISSN
- 2073-4425 (ISSN-L)
- OpenAlex
- W3048418800
- Cited by
- 54
- References
- 17
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of CYP1A2 and ADORA2A Genotypes on the Ergogenic Response to Caffeine in Professional Handball Players. https://app.cochat.ai/papers/10.3390/genes11080933
- The paper
- Muñoz, A., López-Samanes, Á., Aguilar-Navarro, M., Varillas-Delgado, D., Rivilla-García, J., Moreno-Pérez, V., & Del Coso, J. (2020). Effects of CYP1A2 and ADORA2A Genotypes on the Ergogenic Response to Caffeine in Professional Handball Players. Genes. https://doi.org/10.3390/genes11080933
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.